Lamdong Pharmaceutical Joint Stock Company reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported revenue was VND 45,408 million compared to VND 43,465.6 million a year ago. Net loss was VND 2,868.73 million compared to VND 20,557.98 million a year ago. Basic loss per share from continuing operations was VND 226 compared to VND 1,618 a year ago. Diluted loss per share from continuing operations was VND 226 compared to VND 1,618 a year ago.
For the six months, revenue was VND 88,254.98 million compared to VND 93,078.08 million a year ago. Net loss was VND 9,242.42 million compared to VND 18,937.06 million a year ago. Basic loss per share from continuing operations was VND 728 compared to VND 1,491 a year ago. Diluted loss per share from continuing operations was VND 728 compared to VND 1,491 a year ago.